Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “TG Therapeutics, Inc.”

7 pharma patents match "TG Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "TG Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “TG Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11965032

    Anti-CD20 antibody compositions

    TG Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  2. US 11884740

    Anti-CD20 antibody compositions

    TG Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  3. US 11814439

    Anti-CD20 antibody compositions

    TG Therapeutics, Inc. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  4. US 11807689

    Anti-CD20 antibody compositions

    TG Therapeutics, Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  5. US 10966977

    Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders

    TG Therapeutics, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  6. US 10729768

    Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

    TG Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  7. US 9694071

    Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

    TG Therapeutics, Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.